Stabilizing sodium intake is shown to reduce the percentage of patients with lithium level fluctuations above 0.8 mEq/L
Global burden of obesity in 2005 and projections to 2030
They are re-engaging a population in the healthcare system and, in doing so, have handed sleep medicine a golden opportunity to broaden its focus, refine the understanding of non-obesity-related OSA, and deliver more personalized care
Currently available GLP-1 receptor agonists in the United States include exenatide (Byetta, Bydureon BCise), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy, Rybelsus), and tirzepatide (Mounjaro, Zepbound), though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
This keeps the skin plump and supple, reducing dryness and flakiness, and contributing to a healthy glow
Yet unanswered questions regarding this program remain, and the FAQs note that further information will be released in spring 2026